BNLI Randomised trial of Radiation dose in Non-Hodgkin's Lymphoma (NHL)
Not Applicable
Completed
- Conditions
- ymphoma (non-Hodgkin's)CancerLymphoma (non-Hodgkin's)
- Registration Number
- ISRCTN71826974
- Lead Sponsor
- British National Lymphoma Investigation (BNLI) (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 1000
Inclusion Criteria
1. Any patient receiving local radiotherapy (RT) where the aim of the treatment is local control of that lymphoma, whether as radical treatment of Stage I disease, consolidation therapy after chemotherapy or palliation
2. Histological diagnosis of NHL
3. Aged 18 years or over
4. Able to give informed consent
Exclusion Criteria
Not provided at time of registration
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ot provided at time of registration
- Secondary Outcome Measures
Name Time Method ot provided at time of registration